Phibro Animal Health Corporation (PAHC)

Phibro Animal Health Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Net Income	32.61	49.18	54.39	33.55	54.71
Depreciation & Amortization	34.01	32.71	31.89	32.34	27.56
Share-Based Compensation	0	0	1.13	2.26	2.26
Other Operating Activities	-53.31	-50.23	-39.09	-8.8	-37.37
Operating Cash Flow	13.31	31.65	48.31	59.35	47.17
Operating Cash Flow Growth	-57.94%	-34.48%	-18.61%	25.82%	-32.62%
Capital Expenditures	-51.79	-37.04	-29.32	-34.05	-29.89
Acquisitions	0	-13.51	0	-54.55	-9.84
Change in Investments	-23	27.35	12	-31	26
Other Investing Activities	0.78	0.62	-1.26	-0.8	-0.4
Investing Cash Flow	-74.02	-22.58	-18.58	-120.39	-14.13
Dividends Paid	-19.44	-19.44	-19.43	-19.42	-18.59
Share Issuance / Repurchase	0	0	0	0	1.13
Debt Issued / Paid	46.43	40.63	2.44	60.35	13.35
Other Financing Activities	-	-4.84	-	-	-
Financing Cash Flow	26.99	16.34	-17	40.94	-4.11
Exchange Rate Effect	0.75	-1.37	1.14	-1.12	-0.52
Net Cash Flow	-32.97	24.04	13.87	-21.23	28.41
Free Cash Flow	-38.48	-5.4	18.99	25.3	17.28
Free Cash Flow Growth	-	-	-24.97%	46.45%	-66.42%
Free Cash Flow Margin	-3.94%	-0.57%	2.28%	3.16%	2.09%
Free Cash Flow Per Share	-0.95	-0.13	0.47	0.63	0.43

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).